Post-exposure vaccination against Mycobacterium tuberculosis

Area of Science:

• Immunology
• Microbiology
• Veterinary Medicine

Background:

• Enhancing immunity to tuberculosis (TB) in animal models post-infection is challenging.
• Developing effective post-exposure vaccination strategies for TB remains a critical unmet need.

Purpose of the Study:

• To evaluate the efficacy of post-exposure vaccination using fusion protein F36 and Ag85A/ESAT6 vaccines in a guinea pig model of Mycobacterium tuberculosis infection.
• To monitor cellular changes in the lungs using flow cytometry following vaccination after challenge.

Main Methods:

• Guinea pigs were infected with Mycobacterium tuberculosis via low-dose aerosol and vaccinated 10 days later.
• Flow cytometry was used to analyze immune cell populations (CD4+ T cells, heterophils) and CD45+ expression.
• Bacterial load, lung and lymph node pathology, and survival were assessed.

Main Results:

• Vaccination with F36 and Ag85A/ESAT6 reduced bacterial load and heterophils, while increasing CD45+ expression on CD4+ T cells.
• Marginal improvements in lung pathology were observed, but lymph node pathology was unaffected.
• No significant changes in long-term survival were detected despite early beneficial effects.

Conclusions:

• A single post-exposure vaccination can transiently slow tuberculosis disease progression in a guinea pig model.
• This temporary effect could be valuable in multidrug-resistant TB outbreaks, allowing time for diagnostics and treatment initiation.